Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis
Authors:
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 450, 22-31
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81572876, 81773087, 81071736, 30973508)
- Li Ka Shing Foundation
- Shantou University and Technion-Israel Institute of Technology, Shantou University, Guangdong Province
This publication has 40 references indexed in Scilit:
- Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancerBreast Cancer Research, 2012
- Role of Smac in Determining the Chemotherapeutic Response of Esophageal Squamous Cell CarcinomaClinical Cancer Research, 2011
- Global Gene Expression Profiling and Validation in Esophageal Squamous Cell Carcinoma and Its Association with Clinical PhenotypesClinical Cancer Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Cyclin-Dependent Kinase–Mediated Phosphorylation Plays a Critical Role in the Oncogenic Functions of PELP1Cancer Research, 2010
- Genomic Characterization of Esophageal Squamous Cell Carcinoma from a High-Risk Population in ChinaCancer Research, 2009
- Extranuclear Coactivator Signaling Confers Insensitivity to TamoxifenClinical Cancer Research, 2009
- Pyroptosis: host cell death and inflammationNature Reviews Microbiology, 2009
- Role of PELP1/MNAR Signaling in Ovarian TumorigenesisCancer Research, 2008
- Identifying the Estrogen Receptor Coactivator PELP1 in AutophagosomesCancer Research, 2007